Supplementary Figure 9 from Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 24K, HER2/Neu antibody and TCN plus anti-CTLA-4 mAb triple combination treatment increased serum IFN-gamma level
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361260908